GenCrispr NLS-Cas9-EGFP is a fusion protein developed by GenScript. It contains a nuclear localization signal (NLS) on its N terminal end, and an EGFP and a 6x(His) sequence on the C terminal end. Cas9 nuclease is an RNA-guided endonuclease that can catalyze cleavage of double stranded DNA. This kind of targeted nuclease is a powerful tool for genome editing with high precision. Cas9 protein forms a highly stable ribonucleoprotein (RNP) complex with the guide RNA (gRNA) component of the CRISPR/Cas9 system. When Cas9 is expressed with an NLS sequence, the Cas9 RNP complex can localize to the nucleus...
GenCrispr NLS-Cas9-EGFP is a fusion protein developed by GenScript. It contains a nuclear localization signal (NLS) on its N terminal end, and an EGFP and a 6x(His) sequence on the C terminal end. Cas9 nuclease is an RNA-guided endonuclease that can catalyze cleavage of double stranded DNA. This kind of targeted nuclease is a powerful tool for genome editing with high precision. Cas9 protein forms a highly stable ribonucleoprotein (RNP) complex with the guide RNA (gRNA) component of the CRISPR/Cas9 system. When Cas9 is expressed with an NLS sequence, the Cas9 RNP complex can localize to the nucleus...
Shipping & Handling
Shipped In
DRY ICE
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
Regulatory & Compliance
Specifications
CLASS
Proteins, Enzymes
COUNTRY OF ORIGIN
China
*USAGE / SAFETY STATEMENT
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
SIZE
100μg (3mg/ml)
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
DRY ICE
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.